A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes

A. Valipour (Vienna, Austria), P. Shah (London, United Kingdom), F. Herth (Heidelberg, Germany), C. Pison (Grenoble, Finland), C. Schumann (Kempten and Immenstadt, Germany), R. Hübner (Berlin, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasbourg, France), W. Gesierich (Gauting, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), T. Perez (Lille, France), D. Skowasch (Bonn, Germany), G. Deslee (Reims, France), A. Marceau (Paris, France), F. Sciurba (Pittsburgh, United States of America), R. Gosens (Groningen, Netherlands), J. Hartman (Groningen, Netherlands), K. Srikanthan (London, United Kingdom), M. Duller (Vienna, Austria), D. Slebos (Groningen, Netherlands)

Source: International Congress 2019 – Interventional pulmonology: a mixture of spices
Session: Interventional pulmonology: a mixture of spices
Session type: Oral Presentation
Number: 1615

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Valipour (Vienna, Austria), P. Shah (London, United Kingdom), F. Herth (Heidelberg, Germany), C. Pison (Grenoble, Finland), C. Schumann (Kempten and Immenstadt, Germany), R. Hübner (Berlin, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasbourg, France), W. Gesierich (Gauting, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), T. Perez (Lille, France), D. Skowasch (Bonn, Germany), G. Deslee (Reims, France), A. Marceau (Paris, France), F. Sciurba (Pittsburgh, United States of America), R. Gosens (Groningen, Netherlands), J. Hartman (Groningen, Netherlands), K. Srikanthan (London, United Kingdom), M. Duller (Vienna, Austria), D. Slebos (Groningen, Netherlands). A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes. 1615

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: